If you're taking Fosamax or another kind of bisphosphonate drug, you should know about some new findings recently reported by The New England Journal of Medicine and the Food and Drug Administration (FDA). Drug manufacturer Merck has already been dealing with Fosamax lawsuits due to osteonecrosis problems, but the latest findings, which link Fosamax and cancer, open a whole new can of worms for the company. As more and more people come forward with cancer and other medical problems, the case against Fosamax is coming to a head.
There are currently millions of patients taking Fosamax for osteoporosis and other bone diseases. The active ingredients in Fosamax attack and destroy the cells in your bones that cause them to break down. Unfortunately, the drug stays in your body a long time, which means that it can start to affect the healthy bone marrow cells as well, causing osteonecrosis, a condition that usually manifests itself in the jaw and causes pain, immobility, dental problems, and exposed bone. The bone-related problems with Fosamax, however, are somewhat dwarfed by a bigger concern - cancer.
In January 2009, Diane Wysowski of the Food and Drug Administration wrote in the New England Journal of Medicine that as of May 2008, there have been 23 reports of Fosamax patient developing esophageal tumors. Eight of these patients have since passed away. In addition, there have been 21 reports of similar cases in Europe and Japan, with six deaths. Most of these cases showed up at least two years after the patient initially began taking the drug.
Bisphosphonates has been known to cause esophagitis, or inflammation of the esophageal tube, so this was always regarded as one of the main Fosamax risks. Other oral bisphosphonate drugs also cause this condition, and it is much more likely if the medications are not taken as directed. If tumors develop, however, the patient can experience weight loss, coughing with blood, difficulty swallowing, and digestive problems.
There are certain risk factors that make some Fosamax patients more likely to develop esophageal tumors because they're using the drug. For example, patients with Barrett's esophagus are at a much higher risk. However, more studies need to be done in this area, as other conditions may also put people at risk.
Merck has responded to these allegations defensively, saying that the risks are minimal as compared to the benefits for bone disease patients. Still, many doctors disagree, and the number of Fosamax lawsuits are multiplying every month. Merck did not disclose all of the Fosamax risks, and as a result, patients have had to deal with major complications and some have even died.
What can you do to protect yourself? If you are currently using Fosamax, talk to your doctor about your cancer concerns, including your risk factors. This may not be the right medication for you. Remember, if you've had complications due to taking Fosamax or other drugs, contact a lawyer to talk about your rights. You may be entitled to take part in a class action lawsuit with Fosamax, which can help you pay for your medical expenses, lost wages, and more.
Verdicts & Settlements |
Anapol TV |
Our Attorneys |
About Us |
Contact Us |
Site Map |
Fosamax Site Map
Philadelphia, PA | Cherry Hill, NJ | Media, PA | Reading, PA | Harrisburg, PA | Wheeling, WV
Copyright © 2004- - Anapol Schwartz - Pennsylvania Fosamax Attorneys - New Jersey Fosamax Lawyers - Fosamax Class Action Law Firm. All rights reserved.
Fosamax Attorney Disclaimer: This website is dedicated to providing public information regarding Fosamax and other legal information. None of the information on this site is intended to be formal legal advice, nor the formation of a lawyer or attorney client relationship. Please contact a Pennsylvania Fosamax Lawsuit lawyer or Philadelphia Fosamax lawsuit attorney at our law firm for information regarding your particular case. This website is not intended to solicit clients outside the States of New Jersey, Pennsylvania, and West Virginia.